Development of an artificial intelligence-based prediction platform for early recurrence of resectable pancreatic cancer after curative surgery–toward future use as an indication for neoadjuvant treatment: a retrospective multicenter cohort study

Key Points

• The AI-based model predicts early recurrence of resectable pancreatic cancer after surgery.
• Patients identified at high risk may benefit from neoadjuvant treatment to improve outcomes.
• This retrospective multicenter cohort study utilized preoperative parameters for prediction.
• Future prospective studies are necessary to establish clear indications for neoadjuvant treatment.